In conclusion, considering the beneficial effects of certain bacteria in gut homeostasis and the developments in our knowledge of the pathophysiology of IBD, AHR-based treatments emphasizing prebiotics or metabolites made from probiotic bacteria may offer a novel alternative treatment for IBD, owing to the presence of altered AHR signaling with the gut bacterial dysbiosis in IBD patients. This evidence concerns the gene AHR and inflammatory bowel disease.